Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
HSE SummitWebinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory
Commentaries

Subscribe

  • News
  • Watch
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Commentaries
  • Subscribe
  • ADHD
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hidradenitis Suppurativa
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type 2 Diabetes
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
PBMI 2026|
PBMI Innovators|
AIDS 2026|
State of the Industry survey: Share your 2027 outlook
Advertisement

Jana Volante Walshak

Advertisement

Articles by Jana Volante Walshak

DOJ Issues Important Updates to Evaluation of Corporate Compliance Guidance

ByOksana G. Wright,Charles A. DeMonaco,Jana Volante Walshak
July 28th 2020

A strong, up-to-date compliance program should be part of a healthcare company's risk management strategy.

Advertisement

Latest Updated Articles

  • DOJ Issues Important Updates to Evaluation of Corporate Compliance Guidance
    DOJ Issues Important Updates to Evaluation of Corporate Compliance Guidance

    July 28th 2020



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

Ophthalmology coverage hinges on knowing the payer | AAO 2026

2

A conversation about the cycle of ADHD and sleep problems in children, with Alison Pritchard, Ph.D.

3

8 dermatology developments from 2026 that experts say matter most | 2026 Fall Clinical Derm

4

Experts urge earlier JAK inhibitor use in AD and vitiligo | Fall Clinical Derm 2026

5

New acute low back pain guideline steers clinicians away from routine imaging and opioids

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us